Source: The Economic Times

CHEMI: Cadila inks pact with Italian firm to launch generic product in US

The partners plan to launch the product which is a generic version of Sanofi Aventis's Lovenox (Enoxaparin Sodium Injection) in seven dosage strengths in the US, the statement said.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
250-500
Dario Giusti's photo - CEO of CHEMI

CEO

Dario Giusti

CEO Approval Rating

90/100



CHEMI is a Private company. CHEMI generates $317.8K in revenue per employee CHEMI has 1 followers on Owler.